Jeffrey W. Daley (United Kingdom)
university of cambridge Department of PsychologyPoster Author Of 1 e-Poster
P590 - SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF THE OLIGOMER MODULATOR ANLE138B: A FIRST-IN-HUMAN RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 TRIAL (ID 531)
Presenter
Authors
- Johannes Levin (Germany)
- Nand Singh (United Kingdom)
- Sue Melbourne (United Kingdom)
- Amber Morgan (United Kingdom)
- Maria Grazia Spillantini (United Kingdom)
- Michal Wegrzynowicz (United Kingdom)
- Jeffrey W. Daley (United Kingdom)
- Sergey Ryazanov (Germany)
- Andrei Leonov (Germany)
- Christian Griesinger (Germany)
- Felix Schmidt (Germany)
- Daniel Weckbecker (Germany)
- Kai Prager (Germany)
- Torsten Matthias (Germany)
- Armin Giese (Germany)